EMEA (Europe, Middle East and Africa) Interleukin 1 (IL1) Market Report 2017

December 2017 | 119 pages | ID: EDBDF3D9849EN
QYResearch

Abstracts

In this report, the EMEA Interleukin 1 (IL1) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Interleukin 1 (IL1) for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Interleukin 1 (IL1) market competition by top manufacturers/players, with Interleukin 1 (IL1) sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Optimum Therapeutics LLC
• Orphit SAS
• Peptinov SAS
• AbbVie Inc
• Swedish Orphan Biovitrum AB
• TWi Biotechnology Inc
• XBiotech Inc
• Cell Medica Ltd
• Exicure Inc
• Immune Response BioPharma Inc
• Novartis AG
• Omnitura Therapeutics Inc
• Opsona Therapeutics Ltd
• Anacor Pharmaceuticals Inc
• Apexigen Inc
• R Pharm
• Regeneron Pharmaceuticals Inc

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• APX-002
• Canakinumab
• Diacerein CR
• IR-1000
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Esophageal Cancer
• Fallopian Tube Cancer
• Bladder Cancer
• Bechcer Disease
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Interleukin 1 (IL1) Market Report 2017

1 INTERLEUKIN 1 (IL1) OVERVIEW

1.1 Product Overview and Scope of Interleukin 1 (IL1)
1.2 Classification of Interleukin 1 (IL1)
  1.2.1 EMEA Interleukin 1 (IL1) Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Interleukin 1 (IL1) Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 APX-002
  1.2.4 Canakinumab
  1.2.5 Diacerein CR
  1.2.6 IR-1000
  1.2.7 Others
1.3 EMEA Interleukin 1 (IL1) Market by Application/End Users
  1.3.1 EMEA Interleukin 1 (IL1) Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Esophageal Cancer
  1.3.3 Fallopian Tube Cancer
  1.3.4 Bladder Cancer
  1.3.5 Bechcer Disease
  1.3.6 Others
1.4 EMEA Interleukin 1 (IL1) Market by Region
  1.4.1 EMEA Interleukin 1 (IL1) Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Interleukin 1 (IL1) (2012-2022)
  1.5.1 EMEA Interleukin 1 (IL1) Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Interleukin 1 (IL1) Revenue and Growth Rate (2012-2022)

2 EMEA INTERLEUKIN 1 (IL1) COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Interleukin 1 (IL1) Market Competition by Players/Manufacturers
  2.1.1 EMEA Interleukin 1 (IL1) Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Interleukin 1 (IL1) Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Interleukin 1 (IL1) Sale Price by Players (2012-2017)
2.2 EMEA Interleukin 1 (IL1) (Volume and Value) by Type/Product Category
  2.2.1 EMEA Interleukin 1 (IL1) Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Interleukin 1 (IL1) Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Interleukin 1 (IL1) Sale Price by Type (2012-2017)
2.3 EMEA Interleukin 1 (IL1) (Volume) by Application
2.4 EMEA Interleukin 1 (IL1) (Volume and Value) by Region
  2.4.1 EMEA Interleukin 1 (IL1) Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Interleukin 1 (IL1) Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Interleukin 1 (IL1) Sales Price by Region (2012-2017)

3 EUROPE INTERLEUKIN 1 (IL1) (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Interleukin 1 (IL1) Sales and Value (2012-2017)
  3.1.1 Europe Interleukin 1 (IL1) Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Interleukin 1 (IL1) Revenue and Growth Rate (2012-2017)
3.2 Europe Interleukin 1 (IL1) Sales and Market Share by Type
3.3 Europe Interleukin 1 (IL1) Sales and Market Share by Application
3.4 Europe Interleukin 1 (IL1) Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Interleukin 1 (IL1) Sales Volume by Countries (2012-2017)
  3.4.2 Europe Interleukin 1 (IL1) Revenue by Countries (2012-2017)
  3.4.3 Germany Interleukin 1 (IL1) Sales and Growth Rate (2012-2017)
  3.4.4 France Interleukin 1 (IL1) Sales and Growth Rate (2012-2017)
  3.4.5 UK Interleukin 1 (IL1) Sales and Growth Rate (2012-2017)
  3.4.6 Russia Interleukin 1 (IL1) Sales and Growth Rate (2012-2017)
  3.4.7 Italy Interleukin 1 (IL1) Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Interleukin 1 (IL1) Sales and Growth Rate (2012-2017)

4 MIDDLE EAST INTERLEUKIN 1 (IL1) (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Interleukin 1 (IL1) Sales and Value (2012-2017)
  4.1.1 Middle East Interleukin 1 (IL1) Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Interleukin 1 (IL1) Revenue and Growth Rate (2012-2017)
4.2 Middle East Interleukin 1 (IL1) Sales and Market Share by Type
4.3 Middle East Interleukin 1 (IL1) Sales and Market Share by Application
4.4 Middle East Interleukin 1 (IL1) Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Interleukin 1 (IL1) Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Interleukin 1 (IL1) Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Interleukin 1 (IL1) Sales and Growth Rate (2012-2017)
  4.4.4 Israel Interleukin 1 (IL1) Sales and Growth Rate (2012-2017)
  4.4.5 UAE Interleukin 1 (IL1) Sales and Growth Rate (2012-2017)
  4.4.6 Iran Interleukin 1 (IL1) Sales and Growth Rate (2012-2017)

5 AFRICA INTERLEUKIN 1 (IL1) (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Interleukin 1 (IL1) Sales and Value (2012-2017)
  5.1.1 Africa Interleukin 1 (IL1) Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Interleukin 1 (IL1) Revenue and Growth Rate (2012-2017)
5.2 Africa Interleukin 1 (IL1) Sales and Market Share by Type
5.3 Africa Interleukin 1 (IL1) Sales and Market Share by Application
5.4 Africa Interleukin 1 (IL1) Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Interleukin 1 (IL1) Sales Volume by Countries (2012-2017)
  5.4.2 Africa Interleukin 1 (IL1) Revenue by Countries (2012-2017)
  5.4.3 South Africa Interleukin 1 (IL1) Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Interleukin 1 (IL1) Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Interleukin 1 (IL1) Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Interleukin 1 (IL1) Sales and Growth Rate (2012-2017)

6 EMEA INTERLEUKIN 1 (IL1) MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Optimum Therapeutics LLC
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Interleukin 1 (IL1) Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Optimum Therapeutics LLC Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Orphit SAS
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Interleukin 1 (IL1) Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Orphit SAS Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Peptinov SAS
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Interleukin 1 (IL1) Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Peptinov SAS Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 AbbVie Inc
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Interleukin 1 (IL1) Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 AbbVie Inc Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Swedish Orphan Biovitrum AB
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Interleukin 1 (IL1) Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Swedish Orphan Biovitrum AB Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 TWi Biotechnology Inc
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Interleukin 1 (IL1) Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 TWi Biotechnology Inc Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 XBiotech Inc
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Interleukin 1 (IL1) Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 XBiotech Inc Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Cell Medica Ltd
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Interleukin 1 (IL1) Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Cell Medica Ltd Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Exicure Inc
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Interleukin 1 (IL1) Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Exicure Inc Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Immune Response BioPharma Inc
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Interleukin 1 (IL1) Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Immune Response BioPharma Inc Interleukin 1 (IL1) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Novartis AG
6.12 Omnitura Therapeutics Inc
6.13 Opsona Therapeutics Ltd
6.14 Anacor Pharmaceuticals Inc
6.15 Apexigen Inc
6.16 R Pharm
6.17 Regeneron Pharmaceuticals Inc

7 INTERLEUKIN 1 (IL1) MANUFACTURING COST ANALYSIS

7.1 Interleukin 1 (IL1) Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Interleukin 1 (IL1)

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Interleukin 1 (IL1) Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Interleukin 1 (IL1) Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA INTERLEUKIN 1 (IL1) MARKET FORECAST (2017-2022)

11.1 EMEA Interleukin 1 (IL1) Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Interleukin 1 (IL1) Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Interleukin 1 (IL1) Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Interleukin 1 (IL1) Price and Trend Forecast (2017-2022)
11.2 EMEA Interleukin 1 (IL1) Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Interleukin 1 (IL1) Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Interleukin 1 (IL1) Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Interleukin 1 (IL1) Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Interleukin 1 (IL1) Sales Forecast by Type (2017-2022)
11.7 EMEA Interleukin 1 (IL1) Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Interleukin 1 (IL1)
Figure EMEA Interleukin 1 (IL1) Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA Interleukin 1 (IL1) Sales Volume Market Share by Type (Product Category) in 2016
Figure APX-002 Product Picture
Figure Canakinumab Product Picture
Figure Diacerein CR Product Picture
Figure IR-1000 Product Picture
Figure Others Product Picture
Figure EMEA Interleukin 1 (IL1) Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of Interleukin 1 (IL1) by Application in 2016
Figure Esophageal Cancer Examples
Table Key Downstream Customer in Esophageal Cancer
Figure Fallopian Tube Cancer Examples
Table Key Downstream Customer in Fallopian Tube Cancer
Figure Bladder Cancer Examples
Table Key Downstream Customer in Bladder Cancer
Figure Bechcer Disease Examples
Table Key Downstream Customer in Bechcer Disease
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Interleukin 1 (IL1) Market Size (Million USD) by Region (2012-2022)
Figure Europe Interleukin 1 (IL1) Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Interleukin 1 (IL1) Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Interleukin 1 (IL1) Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Interleukin 1 (IL1) Revenue (Million USD) Status and Forecast by Countries
Figure Africa Interleukin 1 (IL1) Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Interleukin 1 (IL1) Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Interleukin 1 (IL1) Sales Volume and Growth Rate (2012-2022)
Figure EMEA Interleukin 1 (IL1) Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Interleukin 1 (IL1) Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA Interleukin 1 (IL1) Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA Interleukin 1 (IL1) Sales Share by Players (2012-2017)
Figure 2016 Interleukin 1 (IL1) Sales Share by Players
Figure 2017 Interleukin 1 (IL1) Sales Share by Players
Figure EMEA Interleukin 1 (IL1) Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Interleukin 1 (IL1) Revenue (Million USD) by Players (2012-2017)
Table EMEA Interleukin 1 (IL1) Revenue Share by Players (2012-2017)
Table 2016 EMEA Interleukin 1 (IL1) Revenue Share by Players
Table 2017 EMEA Interleukin 1 (IL1) Revenue Share by Players
Table EMEA Interleukin 1 (IL1) Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA Interleukin 1 (IL1) Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA Interleukin 1 (IL1) Sales Share by Type (2012-2017)
Figure Sales Market Share of Interleukin 1 (IL1) by Type (2012-2017)
Figure EMEA Interleukin 1 (IL1) Sales Market Share by Type (2012-2017)
Table EMEA Interleukin 1 (IL1) Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Interleukin 1 (IL1) Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Interleukin 1 (IL1) by Type in 2016
Table EMEA Interleukin 1 (IL1) Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA Interleukin 1 (IL1) Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA Interleukin 1 (IL1) Sales Share by Application (2012-2017)
Figure Sales Market Share of Interleukin 1 (IL1) by Application (2012-2017)
Figure EMEA Interleukin 1 (IL1) Sales Market Share by Application in 2016
Table EMEA Interleukin 1 (IL1) Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA Interleukin 1 (IL1) Sales Share by Region (2012-2017)
Figure Sales Market Share of Interleukin 1 (IL1) by Region (2012-2017)
Figure EMEA Interleukin 1 (IL1) Sales Market Share in 2016
Table EMEA Interleukin 1 (IL1) Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Interleukin 1 (IL1) Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Interleukin 1 (IL1) by Region (2012-2017)
Figure EMEA Interleukin 1 (IL1) Revenue Market Share Regions in 2016
Table EMEA Interleukin 1 (IL1) Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe Interleukin 1 (IL1) Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Interleukin 1 (IL1) Revenue and Growth Rate (2012-2017)
Table Europe Interleukin 1 (IL1) Sales (K Pcs) by Type (2012-2017)
Table Europe Interleukin 1 (IL1) Market Share by Type (2012-2017)
Figure Europe Interleukin 1 (IL1) Market Share by Type in 2016
Table Europe Interleukin 1 (IL1) Sales (K Pcs) by Application (2012-2017)
Table Europe Interleukin 1 (IL1) Market Share by Application (2012-2017)
Figure Europe Interleukin 1 (IL1) Market Share by Application in 2016
Table Europe Interleukin 1 (IL1) Sales (K Pcs) by Countries (2012-2017)
Table Europe Interleukin 1 (IL1) Sales Market Share by Countries (2012-2017)
Figure Europe Interleukin 1 (IL1) Sales Market Share by Countries (2012-2017)
Figure Europe Interleukin 1 (IL1) Sales Market Share by Countries in 2016
Table Europe Interleukin 1 (IL1) Revenue (Million USD) by Countries (2012-2017)
Table Europe Interleukin 1 (IL1) Revenue Market Share by Countries (2012-2017)
Figure Europe Interleukin 1 (IL1) Revenue Market Share by Countries (2012-2017)
Figure Europe Interleukin 1 (IL1) Revenue Market Share by Countries in 2016
Figure Germany Interleukin 1 (IL1) Sales (K Pcs) and Growth Rate (2012-2017)
Figure France Interleukin 1 (IL1) Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK Interleukin 1 (IL1) Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia Interleukin 1 (IL1) Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy Interleukin 1 (IL1) Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux Interleukin 1 (IL1) Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Interleukin 1 (IL1) Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Interleukin 1 (IL1) Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Interleukin 1 (IL1) Sales (K Pcs) by Type (2012-2017)
Table Middle East Interleukin 1 (IL1) Market Share by Type (2012-2017)
Figure Middle East Interleukin 1 (IL1) Market Share by Type (2012-2017)
Table Middle East Interleukin 1 (IL1) Sales (K Pcs) by Applications (2012-2017)
Table Middle East Interleukin 1 (IL1) Market Share by Applications (2012-2017)
Figure Middle East Interleukin 1 (IL1) Sales Market Share by Application in 2016
Table Middle East Interleukin 1 (IL1) Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East Interleukin 1 (IL1) Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Interleukin 1 (IL1) Sales Volume Market Share by Countries in 2016
Table Middle East Interleukin 1 (IL1) Revenue (Million USD) by Countries (2012-2017)
Table Middle East Interleukin 1 (IL1) Revenue Market Share by Countries (2012-2017)
Figure Middle East Interleukin 1 (IL1) Revenue Market Share by Countries (2012-2017)
Figure Middle East Interleukin 1 (IL1) Revenue Market Share by Countries in 2016
Figure Saudi Arabia Interleukin 1 (IL1) Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel Interleukin 1 (IL1) Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE Interleukin 1 (IL1) Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran Interleukin 1 (IL1) Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Interleukin 1 (IL1) Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Interleukin 1 (IL1) Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Interleukin 1 (IL1) Sales (K Pcs) by Type (2012-2017)
Table Africa Interleukin 1 (IL1) Sales Market Share by Type (2012-2017)
Figure Africa Interleukin 1 (IL1) Sales Market Share by Type (2012-2017)
Figure Africa Interleukin 1 (IL1) Sales Market Share by Type in 2016
Table Africa Interleukin 1 (IL1) Sales (K Pcs) by Application (2012-2017)
Table Africa Interleukin 1 (IL1) Sales Market Share by Application (2012-2017)
Figure Africa Interleukin 1 (IL1) Sales Market Share by Application (2012-2017)
Table Africa Interleukin 1 (IL1) Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa Interleukin 1 (IL1) Sales Market Share by Countries (2012-2017)
Figure Africa Interleukin 1 (IL1) Sales Market Share by Countries (2012-2017)
Figure Africa Interleukin 1 (IL1) Sales Market Share by Countries in 2016
Table Africa Interleukin 1 (IL1) Revenue (Million USD) by Countries (2012-2017)
Table Africa Interleukin 1 (IL1) Revenue Market Share by Countries (2012-2017)
Figure Africa Interleukin 1 (IL1) Revenue Market Share by Countries (2012-2017)
Figure Africa Interleukin 1 (IL1) Revenue Market Share by Countries in 2016
Figure South Africa Interleukin 1 (IL1) Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria Interleukin 1 (IL1) Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt Interleukin 1 (IL1) Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria Interleukin 1 (IL1) Sales (K Pcs) and Growth Rate (2012-2017)
Table Optimum Therapeutics LLC Interleukin 1 (IL1) Basic Information List
Table Optimum Therapeutics LLC Interleukin 1 (IL1) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Optimum Therapeutics LLC Interleukin 1 (IL1) Sales (K Pcs) and Growth Rate (2012-2017)
Figure Optimum Therapeutics LLC Interleukin 1 (IL1) Sales Market Share in EMEA (2012-2017)
Figure Optimum Therapeutics LLC Interleukin 1 (IL1) Revenue Market Share in EMEA (2012-2017)
Table Orphit SAS Interleukin 1 (IL1) Basic Information List
Table Orphit SAS Interleukin 1 (IL1) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Orphit SAS Interleukin 1 (IL1) Sales (K Pcs) and Growth Rate (2012-2017)
Figure Orphit SAS Interleukin 1 (IL1) Sales Market Share in EMEA (2012-2017)
Figure Orphit SAS Interleukin 1 (IL1) Revenue Market Share in EMEA (2012-2017)
Table Peptinov SAS Interleukin 1 (IL1) Basic Information List
Table Peptinov SAS Interleukin 1 (IL1) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Peptinov SAS Interleukin 1 (IL1) Sales (K Pcs) and Growth Rate (2012-2017)
Figure Peptinov SAS Interleukin 1 (IL1) Sales Market Share in EMEA (2012-2017)
Figure Peptinov SAS Interleukin 1 (IL1) Revenue Market Share in EMEA (2012-2017)
Table AbbVie Inc Interleukin 1 (IL1) Basic Information List
Table AbbVie Inc Interleukin 1 (IL1) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure AbbVie Inc Interleukin 1 (IL1) Sales (K Pcs) and Growth Rate (2012-2017)
Figure AbbVie Inc Interleukin 1 (IL1) Sales Market Share in EMEA (2012-2017)
Figure AbbVie Inc Interleukin 1 (IL1) Revenue Market Share in EMEA (2012-2017)
Table Swedish Orphan Biovitrum AB Interleukin 1 (IL1) Basic Information List
Table Swedish Orphan Biovitrum AB Interleukin 1 (IL1) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Swedish Orphan Biovitrum AB Interleukin 1 (IL1) Sales (K Pcs) and Growth Rate (2012-2017)
Figure Swedish Orphan Biovitrum AB Interleukin 1 (IL1) Sales Market Share in EMEA (2012-2017)
Figure Swedish Orphan Biovitrum AB Interleukin 1 (IL1) Revenue Market Share in EMEA (2012-2017)
Table TWi Biotechnology Inc Interleukin 1 (IL1) Basic Information List
Table TWi Biotechnology Inc Interleukin 1 (IL1) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure TWi Biotechnology Inc Interleukin 1 (IL1) Sales (K Pcs) and Growth Rate (2012-2017)
Figure TWi Biotechnology Inc Interleukin 1 (IL1) Sales Market Share in EMEA (2012-2017)
Figure TWi Biotechnology Inc Interleukin 1 (IL1) Revenue Market Share in EMEA (2012-2017)
Table XBiotech Inc Interleukin 1 (IL1) Basic Information List
Table XBiotech Inc Interleukin 1 (IL1) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure XBiotech Inc Interleukin 1 (IL1) Sales (K Pcs) and Growth Rate (2012-2017)
Figure XBiotech Inc Interleukin 1 (IL1) Sales Market Share in EMEA (2012-2017)
Figure XBiotech Inc Interleukin 1 (IL1) Revenue Market Share in EMEA (2012-2017)
Table Cell Medica Ltd Interleukin 1 (IL1) Basic Information List
Table Cell Medica Ltd Interleukin 1 (IL1) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Cell Medica Ltd Interleukin 1 (IL1) Sales (K Pcs) and Growth Rate (2012-2017)
Figure Cell Medica Ltd Interleukin 1 (IL1) Sales Market Share in EMEA (2012-2017)
Figure Cell Medica Ltd Interleukin 1 (IL1) Revenue Market Share in EMEA (2012-2017)
Table Exicure Inc Interleukin 1 (IL1) Basic Information List
Table Exicure Inc Interleukin 1 (IL1) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Exicure Inc Interleukin 1 (IL1) Sales (K Pcs) and Growth Rate (2012-2017)
Figure Exicure Inc Interleukin 1 (IL1) Sales Market Share in EMEA (2012-2017)
Figure Exicure Inc Interleukin 1 (IL1) Revenue Market Share in EMEA (2012-2017)
Table Immune Response BioPharma Inc Interleukin 1 (IL1) Basic Information List
Table Immune Response BioPharma Inc Interleukin 1 (IL1) Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Immune Response BioPharma Inc Interleukin 1 (IL1) Sales (K Pcs) and Growth Rate (2012-2017)
Figure Immune Response BioPharma Inc Interleukin 1 (IL1) Sales Market Share in EMEA (2012-2017)
Figure Immune Response BioPharma Inc Interleukin 1 (IL1) Revenue Market Share in EMEA (2012-2017)
Table Novartis AG Interleukin 1 (IL1) Basic Information List
Table Omnitura Therapeutics Inc Interleukin 1 (IL1) Basic Information List
Table Opsona Therapeutics Ltd Interleukin 1 (IL1) Basic Information List
Table Anacor Pharmaceuticals Inc Interleukin 1 (IL1) Basic Information List
Table Apexigen Inc Interleukin 1 (IL1) Basic Information List
Table R Pharm Interleukin 1 (IL1) Basic Information List
Table Regeneron Pharmaceuticals Inc Interleukin 1 (IL1) Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Interleukin 1 (IL1)
Figure Manufacturing Process Analysis of Interleukin 1 (IL1)
Figure Interleukin 1 (IL1) Industrial Chain Analysis
Table Raw Materials Sources of Interleukin 1 (IL1) Major Manufacturers in 2016
Table Major Buyers of Interleukin 1 (IL1)
Table Distributors/Traders List
Figure EMEA Interleukin 1 (IL1) Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA Interleukin 1 (IL1) Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Interleukin 1 (IL1) Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA Interleukin 1 (IL1) Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA Interleukin 1 (IL1) Sales Market Share Forecast by Region (2017-2022)
Table EMEA Interleukin 1 (IL1) Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Interleukin 1 (IL1) Revenue Market Share Forecast by Region (2017-2022)
Table Europe Interleukin 1 (IL1) Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe Interleukin 1 (IL1) Sales Market Share Forecast by Countries (2017-2022)
Table Europe Interleukin 1 (IL1) Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Interleukin 1 (IL1) Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Interleukin 1 (IL1) Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East Interleukin 1 (IL1) Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Interleukin 1 (IL1) Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Interleukin 1 (IL1) Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Interleukin 1 (IL1) Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa Interleukin 1 (IL1) Sales Market Share Forecast by Countries (2017-2022)
Table Africa Interleukin 1 (IL1) Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Interleukin 1 (IL1) Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Interleukin 1 (IL1) Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA Interleukin 1 (IL1) Sales Market Share Forecast by Type (2017-2022)
Table EMEA Interleukin 1 (IL1) Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA Interleukin 1 (IL1) Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources